Concepedia

Alan Lichtenstein

AL

119

Publications

11.9K

Citations

56

H-Index

1980

Active since

Affiliations

University of California, Los Angeles(Current)

UCLA Jonsson Comprehensive Cancer Center

West Los Angeles College

VA Greater Los Angeles Healthcare System

Wadsworth Center

Alan Lichtenstein is an author at University of California, Los Angeles specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

1980–2020

119

Publications

119

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

Elizabeta Nemeth, Erika V. Valore, Mary Territo et al. · Blood · 2003 · 1.4K citations · Full text

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

James R. Berenson, Alan Lichtenstein, Lester Porter et al. · New England Journal of Medicine · 1996 · 1.1K citations

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

James R. Berenson, Alan Lichtenstein, Lisa A. Porter et al. · Journal of Clinical Oncology · 1998 · 652 citations

Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade

Yijiang Shi, Huajun Yan, Patrick Frost et al. · Molecular Cancer Therapeutics · 2005 · 369 citations · Full text

Apoptotic vs. Nonapoptotic Cytotoxicity Induced by Hydrogen Peroxide

Agnes Gardner, Fenghao Xu, Catherine Fady et al. · Free Radical Biology and Medicine · 1997 · 356 citations

, , +7

Rows per page

1–5 of 119